Incidence of hepatocellular carcinoma in hiv-infected patients with cirrhosis: A prospective study

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 1, 2014, Pages 82-86

  Ramírez, María Luisa Montes ^a   Miró, José M ^b   Quereda, Carmen ^c   Jou, Antoni ^d   Von Wichmann, Miguel Ángel ^e   Berenguer, Juan ^f   González García, Juan J ^a   Hernando, Asunción ^g   Ortega, Enrique ^h   Sanz, José ⁱ   Arribas, José R ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL DONOSTIA   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Hepatocellular carcinoma; HIV; Incidence; Liver cirrhosis; Viral hepatitis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; CANCER INCIDENCE; CANCER PATIENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; TREATMENT DURATION; VIRUS LOAD;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84893740449     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182a685dc     Document Type: Review

References (21)

1. González-García J, Navarro San Francisco C, Condes E, et al. Evaluación de la prevalencia de la coinfección por VHC, características de la hepatopatía y tratamiento específico de los pacientes infectados por VIH en España. Estudio GESIDA 57/07. IV Congreso Nacional de GESIDA, Toledo, November 27-30, 2012, PO41.
2. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492-497.
3. Martín-Carbonero L, Soriano V, Valencia E, et al. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIVinfected patients. AIDS Res Hum Retroviruses. 2001;17:1467-1471.
4. Salmon-Ceron D, Rosenthal E, Lewden C, et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French National Mortalité 2005 Study. J Hepatol. 2009;50: 736-745.
5. Ioannou GN, Bryson CL, Weiss NS, et al. The prevalence of cirrhosis and hepatocellular carcinoma in patients with HIV infection. Hepatology. 2013;57:249-257.
6. Sulkowski M. Hepatocellular carcinoma in HIV-infected patients comes of age: the convergence of epidemiology and treatment effectiveness. J Hepatol. 2009;50:655-658.
7. Pineda JA, García-García JA, Aguilar-Guisado M, et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology. 2007;46:622-630.
8. Bräu N, Salvatore M, Ríos-Bedoya CF, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol. 2006;44:47-55.
9. García-García JA, Romero-Gómez M, Girón-González JA, et al. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis. AIDS Res Hum Retroviruses. 2006;22: 1236-1241.
10. Kramer JR, Giordano TP, Souchek J, et al. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol. 2005;100:56-63.
11. Bruno R, Sacchi P, Puoti M, et al. Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. J Acquir Immune Defic Syndr. 2007;46:297-303.
12. Merchante N, Merino E, López-Aldeguer J, et al. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis. 2013;56:143-150.
13. Bruyand M, Dabis F, Vandenhende MA, et al. HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008. J Hepatol. 2011;55:1058-1062.
14. López-Diéguez M, Montes ML, Pascual-Pareja JF, et al. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. AIDS. 2011;25:899-904.
15. Forner A, Ayuso C, Real MI, et al. Diagnosis and treatment of hepatocellular carcinoma [in Spanish]. Med Clin (Barc). 2009;132:272-287.
16. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
17. Bonacini M, Hadi G, Govindarajan S, et al. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92:1302-1304.
18. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56:908-943.
19. Murillas J, Del Río M, Riera M, et al. Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients. Eur J Intern Med. 2005;16:113-115.
20. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
21. García-Samaniego J, Rodríguez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol. 2001;96:179-183.